greeksoup/ stock research

Eli Lilly (LLY) FY2021 results: revenue $28.3 billion, up 15.4% on the year

Eli Lilly & Co. (LLY) reported revenue of $28.3 billion for fiscal 2021, the year ended 31 December 2021, up 15.4% on the year before. Net income was $5.6 billion, down 9.9%, and diluted earnings per share $6.12. The figures are the company's own, from the 10-K it filed with the SEC on 23 February 2022.

Revenue
$28.3 billion
+15.4% on the year
FY2014FY2021
Operating margin
n/a
FY2014FY2021
Net income
$5.6 billion
-9.9% on the year
FY2014FY2021
Diluted EPS
$6.12
-9.9% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue28,31824,54022,320+15.4%
Cost of revenue7,3135,4834,721+33.4%
Gross profit21,00619,05617,598+10.2%
Gross margin74.2%77.7%78.8%
Research and development6,9315,9765,595+16.0%
Selling, general and administrative6,4326,1216,214+5.1%
Interest expense340360401-5.5%
Pre-tax income6,1567,2305,266-14.9%
Income tax5741,036628-44.6%
Effective tax rate9.3%14.3%11.9%
Net income5,5826,1948,318-9.9%
Net margin19.7%25.2%37.3%
Diluted EPS$6.12$6.79$8.89-9.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow7,3666,5004,837+13.3%
Capital expenditure1,3101,3881,034-5.6%
Free cash flow6,0565,1123,803+18.5%
Free cash flow margin21.4%20.8%17.0%
Cash from investing-2,868-2,259-8,083
Cash from financing-4,131-3,137-2,324
Depreciation and amortisation1,5481,3241,233+16.9%
Share-based compensation343308312+11.3%
Buybacks1,2505004,400+150.0%
Dividends paid3,0872,6872,410+14.9%
Dividend per share$3.53$3.07$2.68+15.0%
Diluted shares, weighted912m913m936m-0.1%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity8,9795,6422,607+59.2%
Non-controlling interest17618492.2-4.4%
Debt16,88516,59515,317+1.7%
Operating lease liabilitiesn/an/a487
Other liabilities22,76624,21320,783-6.0%
Total liabilities and equity48,80646,63339,286+4.7%
Fixed assets8,9858,6827,873+3.5%
Goodwill3,8923,7663,679+3.3%
Intangible assets7,6927,4506,618+3.2%
Investments3,3032,9912,063+10.4%
Cash and equivalents3,8183,6572,338+4.4%
Receivables6,6735,8754,547+13.6%
Inventory3,8863,9803,191-2.4%
Other assets10,55710,2318,977+3.2%
Total assets48,80646,63339,286+4.7%

10-K for the year ended 31 December 2021, filed 23 February 2022: the filing.